chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Currently breast feeding.  Son born 12 weeks ago. I started spotting for the first time at around 4am on 16 OCT 21.  It appears my menstrual cycle has started. I have had no spotting or bleeding while breast feeding after healing from birth of son. I have not reduced the amount of nursing I have done at all over the last 12 weeks. I found this odd and wanted to report it.
Pain at  and around injection site in arm, body aches, fever, headache, sinus pressure
pt recv vax  & eye swelled & very drowsy;paramedics transported pt to hosp;
Patient reported he was dizzy and felt "out of it".  During assessment he began to report sour taste in mouth and burning/itching in throat. Benadryll 25mg IM and EPI-pen 0.3 mg were administered and effective.  Pt was transported to ED for evaluation.
Patient called on 04/13/2021 at 110pm reporting that when she woke up today, 04/13/2021 she had some blood on her pillow and said that the blood came out of her mouth.   She did not think that she vomited the blood.  She also reported some chills and worm feelings.
I once again (refer to VAERS report # 937341) began to experience a high blood pressure spike the evening of 1/16/23 after taking 2mg Cialis. My BP went to 196/115. I immediately began taking Clonidine at 0.05 mg (still having it after ER visits in May 2022) until I got my BP to come down. The began a full week of chasing my High BP with Clonidine. During which time I had extreme heart fatigue, brain fog, mild headache and anxiety of my BP. No nose bleeds this time.
9 x 9.5 cm red area to left deltoid area warm, mildly tender. Cool compresses and BENADRYL recommended.
arm was swell; sick; Initial information was received on 15-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via media.  This case is linked with case 2020SA292550.  This case involves an adult patient exact age unknown and gender unspecified whose arm was swell (peripheral swelling) and sick for two weeks (illness), while he/she received vaccine INFLUENZA VACCINE.  It was unknown if the patient had any medical history, concomitant disease or risk factor and the patient's past medical treatment(s), vaccination(s), family history and concomitant medication were not reported   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in 2002, the patient's arm was swell (peripheral swelling) and sick for two weeks (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if the patient experienced any additional symptoms/events. Medication details and reason for taking the medicine: Product Name: Product name was not provided. Since this was a public post on the Sanofi flu shot campaign it was assumed that the consumer was referring to the Sanofi flu vaccine.   Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  On an unknown date, patient had recovered from the events.  There will be no information available on batch number for this case.
On April 26, 2021, I received my 2nd Pfizer Vaccine Shot  in my Left Arm and felt a little soreness the early part of the night around  8:00 PM and throughout the night the soreness became intense  and the next morning I put some 70% Alcohol on the Left arm and right arm.  I noticed that I kept feeling discomfort with Pain  & Soreness in the Left Arm that was Vaccinated but also felt Pain and Soreness in the Right Arm that was never vaccinated.,  Took Extra Strength Tylenol 500 Milligrams Use 70% Green Alcohol on the Left Arm that Vaccinated and the Right Arm that wasn't Vaccinated Took Generic Muscle Relaxer called Methocarbamol
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 03-JUN-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 144 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 144 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Pain in arm; This case was reported by a consumer and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced pain in arm. The patient was treated with ibuprofen. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that things were going well and patient had more pain. The reporter did not consent to follow up. This case linked with US2019AMR199221, reported for patient's wife.
Two months after being fully vaccinated, patient's left arm continues to hurt and is unable to apply pressure onto that arm.  Patient states that the pain she feels in her arm also extends to her left leg. patient describes the pain as persistent, hot sensation as if it reaches her bone.
09/30/2021 Chief Complaint  Patient presents with  ? Nasal Congestion  sx started Monday  ? Sinus Problem  ? Vomiting  ? Diarrhea  ? Chills  ? Cough   79 year old patient presents with 3 days of N/V/D, cough, nasal congestion, wheezing, rhinorhea, and chills. Has been vaccinated in 4/2021 with Pfizer. Went camping over the weekend and found out that 43 of his friends tested (+) for COVID 19 who he was camping with.  Taking:Albuterol inhaler. Tylenol BID. FLonase daily  Outpatient COVID-19 Testing Provider Testing Criteria Decision Support   Symptoms: (X ) Fever (X ) Shortness of breath (X ) Cough (X ) Sore throat (X ) Diarrhea ( ) Loss of taste/smell ( X) Other N/V, rhinorrhea, HA, wheezing ( ) None  When did symptoms start? 3 days  ED to Hosp-Admission  Discharged 10/4/2021 - 10/9/2021 (5 days) Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Principal problem Hospital Problems          POA   * (Principal) Acute hypoxemic respiratory failure due to COVID-19 (CMS/HCC) Yes                    Plan     Chief Complaint Patient presents with ? Shortness of Breath     1. Acute hypoxemic respiratory failure secondary to COVID-19 pneumonitis.  Admit to general medical floor.  Start patient on IV remdesivir, Decadron therapy.  Check procalcitonin, inflammatory markers.  Wean supplemental oxygen as tolerated to keep SaO2 greater than 90.  Encourage proning. 2. Hyponatremia.  Given concurrent hypochloremia, likely represents dehydration.  Gentle IV hydration x24 hours.  Monitor BMP. 3. Hypertension.  Blood pressures appear well controlled, continue home regimen. 4. Atrial fibrillation.  On Eliquis for anticoagulation, continue beta-blocker.  Monitor on telemetry. 5. Dyslipidemia.  Continue statin therapy. 6. Type 2 diabetes.  Continue long-acting insulin per home regimen.  Hold oral hypoglycemics.  Will place on insulin sliding scale and Accu-Cheks per protocol.    History of Present Illness     Patient is an 79 y.o. male.    With past medical history significant for A. fib on Eliquis, hypertension, dyslipidemia, diabetes presented to the emergency room for evaluation of hypoxia.  Home health nurse found the patient to be hypoxic, oxygen saturation in the 80s on room air today.  Patient was diagnosed with Covid about 13 days ago, does not use any oxygen at baseline.  Denies any associated fevers, nausea or vomiting.  Does endorse chest tightness, abdominal discomfort, particularly with coughing.  Cough is productive of gray sputum.  Initial work-up in the emergency room includes CBC within normal limits, BMP with evidence of hyponatremia, hypochloremia.  Troponin negative x1 set, LFTs show mildly abnormal AST 55, albumin 3.2.  BNP normal.  Respiratory viral panel confirms SARS-CoV-2 infection.  A 1 view chest x-ray shows bilateral infiltrates, consistent with COVID-19 infection.  Patient has been administered 6 mg IV Decadron in the ER, and endorsed for hospitalization for further management of acute hypoxic respiratory failure from Covid 19 infection.
SWOLLEN EYE INFECTION HAD POCKETS OF LIQUID TOOK PRESCRIPTION EYE DROP (CIPROFLOXACINE). VERY PAINFUL IMPARED VISION
Large red swollen area at site of injection.  I was given Keflex and Benadryl.
This spontaneous report as received from a physician who stated that an unspecified amount of MMR II that was unsupported due to a temperature excursion, may have been administered to an unspecified number of patients. The temperature excursion occurred in December of 2012 and an unknown number of patients may had been affected. Additional information has been requested.
This spontaneous report was received from a physician referring to a 13-year-old patient of unknown gender. Pertinent medical history or concurrent conditions were not reported. On 07-AUG-2017, the patient was vaccinated with improperly stored dose of VAQTA (lot # N005274, expiration date 03-APR-2018) (dosage information and route were not informed). Information regarding concomitant medication was not provided. Additionally, it was reported that the lowest temperature was 32°F and the higher was 54°F for 70 hours. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one of several cases from the same reporter. Sender's Comments: US-009507513-1709USA007325: US-009507513-1709USA012768.
Ataxic gait on 12/3/08,  Flu vaccine 11/17. 3/19/09 MR received from PCP which include neuro consults.  Pt seen 11/17/08 for URI sx. Flu vax given. TC from parent 12/5/08 reporting child's balance is off, falling alot x 4 days. No other sx. Seen 12/6/08. PE (+) for clumsy gait, otherwise WNL. To observe. Assessment:  Clumsiness. Seen in neuro consult 12/9 and 12/12/08.  PE (+) for wide-based ataxic gait and increased muscle tone in extremities. DX:  Likely post-infectious cerebellitis. ? oposclonus-myoclonus ataxia syndrome. Improving by 12/30/08 but some intermittent hand tremulousness noted by parent. Final dx:  cerebellar ataxia.
On day of vaccine started with pain it severe soreness to lt arm. Next day 9/6/13 at around 4PM started achy ness especially to legs. Took Tylenol 500. Started less in-off. Same day at nite. Started with pain with inflammation to lymph node - pain to touch.  Cephalexin 500g given to take. Dx'd with cellulitis to deltoid area.
11/18/22 presents to ED for "breathing problem". PMHx of "COPD, hx of PE, and GERD"
headache; migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), administration date: 05Feb2021, for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; MIGRAINE (non-serious), outcome "unknown", described as "migraine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
8 cm erythemic, ecchymotic area of induration at the injection site and same sided neck pain (right).
Information has been received from a RN concerning a female pt who a few days ago in approx Sept 2004 was vaccinated IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the injection site became very red, swollen and edematous. The affected area spread all the way down to her elbow. There were no hives or shortness of breath. The reporter did not know if the pt ever had a dose of pneumococcal 23v polysaccharide vaccine before. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
pt c/o becoming ill w/in 1 hr of shot; pt felt weak, hot & cold flashes, loss of appetite, wanted to sleep all weekend; felt a little better, then 3-4 days ago became sick again; c/o croup like cough, vomiting;
Panic attack after 15 minutes of the injection. Than more panic attacks the next day (4/2)
arm swollen and red, very irritated able to feel lump in the arm; lump has gotten smaller but still able to feel it upon touch; patient having trouble lifting arm and performing normal duties with arm; still hurts ; went to dr and was told to come back to the pharmacy
Dizzy when standing up, quickly felt better. BP 131/71 (pulse 65, O2 sat 98%), 106/56 (pulse 61, O2 sat 100%). Discharged to home.
Headaches began 24 hours after vaccination and are currently still persisting a week later. Pain and tenderness at injection site, as well as edema, erythema, and urticaria at injection site are currently persisting.
Identified an adult patient received an adolescent dose of HEP B. Incident reported to our organization's risk manager and patient's PCP informed. Reviewed consequences and next steps with our risk management team and pharmacy consultant. Reported event on VAERS, contacted patient and scheduled patient for appointment for the second HEP B dose.
The flu shot gave patient the flu; Initial information received on 28-Oct-2020 regarding an unsolicited valid non-serious social media case received from a consumer.  This case is linked to cases 2020SA305873 and 2020SA305878.  This case involves a patient to whom flu shot gave the flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, patient got the flu (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was influenza.   Relevant laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as Unknown.  There will be no information available on the batch number for this case.
This spontaneous report as received from a public health, healthcare professional refers to unspecified patients of unknown age and gender. On an unknown date the unspecified patients might had vaccinated with improperly stored M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 53F for 12 hours and M-M-R II (lot#, dose, frequency and route unspecified), which were exposed to 54F for five hours. No adverse effects reported. Follow up information has been received from an office manager concerning a patient. On 19-NOV-2013 the patient was vaccinated with improperly stored M-M-R II (lot# J006954, exp. 07-JUN-2015), which were exposed to 54F for 5 hours (date excursion ended 06-SEP-2013). This is one of several reports received from the same source (linked MARRS#: 1311USA007619, 1311USA011609, 1311USA011610, 1311USA011611, 1311USA011612, 1311USA011613, 1311USA011614, 1311USA011616, 1311USA011615, 1311USA011617, 1311USA011618). Additional information has been requested.
PATIENT CALLED TODAY REPORTING FEVER, AND STOMACH UPSET, DRY LIPS BEGINNING SATURDAY 9/2, SUNDAY 9/3  PATIENT REPORTED FEVER BLISTERS STARTING AND THEN PROGRESSING ON BOTH TOP AND BOTTOM LIP.  I REACHED OUT TO THE PRIMARY CARE DOCTOR AND REPORTED PATIENT'S SYMPTOMS AS SHE REPORTED TO ME ON THE PHONE.  ACCORDING TO THE PATIENT, ONE OF THE DOCTORS AT HER PRIMARY CARE OFFICE CALLED IN A PRESCRIPTION FOR HER TO ANOTHER PHARMACY WHERE SHE NORMALLY GETS RXS FILLED
On 09/09/2022 I started presenting COVID 19 symptoms; headache; fever; nausea; severe body aches; nasal and chest congestion; fever of 102-101. On 9/10/2022 I tested positive. My symptoms lasted for the next 3 days.
Approximately 2 hrs after my vaccine I got a tightening sensation in my throat, followed by a hot flash all over my body. That subsided but I had a lump in my throat feeling. I did not have difficulty breathing or swallowing. I rested after. Every day since I have dealt with esophageal issues/globus sensation. I have since had multiple tests costing me a lot of money and trying to figure out what is wrong with my throat.
Persistent temperature 104-105F seen in ER seen in MD office twice temp 105. Referred to ER.
Chest and back itch incredibly; Does feel hot; now swelling of his face or throat; now swelling of his face or throat; This is a spontaneous report from a contactable consumer or other non-healthcare professional (Patient's father). An 18-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, batch/lot number: EN0187 and Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 25Jun2021 14:30 (at the time of vaccination 18-years-old), as a single dose for COVID-19 immunization. The patient's medical history include sunburn and reported that he did have a sunburn 3 days ago. No concomitant medications were not reported. The caller provided other relevant medical history including but not limited to these conditions; diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity. The patient did not have any other vaccination prior to COVID vaccine (within 4 weeks). No family Medical History Relevant to adverse events. On 25Jun2021, the patient experienced chest and back itch incredibly, does feel hot, and now swelling of his face or throat. It was reported that, today (25Jun2021) the caller 18-year-old son had the Covid-19 vaccination. He had the vaccine about 2 hours ago. Everything was fine up until about 30 minutes ago. He claims his chest and back itch incredibly. He had no other symptoms and no rash. He does feel hot. He had no difficulty breathing and now swelling of his face or throat. The caller wife was a nurse. She did not feel like it was an emergency at that point but being a nurse, she wanted him to check and see if they have any Benadryl. No relevant tests. Patient did not visit to emergency room, physician office and not hospitalized. The outcome for all the events was not resolved.  Additional Information has been requested.
Fever (103.7), chills, myalgia, headache, nausea (mild), fatigue.  Approximately 2hours after vaccine. Took Tylenol 1000mg at time of vaccine. Tylenol and Motrin alternated around the clock. Still with fever.
increased asthma symptoms which brought me into the red zone; tightness of chest; coughing; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non healthcare professional). The reporter is the patient.  A 54 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Dec2021 13:15 (Lot number: FH8027) at the age of 54 years as DOSE 3 (BOOSTER), SINGLE for covid-19 immunization. Relevant medical history included: "Asthma (allergy and non-allergy triggered)" (unspecified if ongoing); "Known allergies: sulpha based antibiotics" (unspecified if ongoing). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient did diagnose with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication(s) included: QVAR; ALBUTEROL [SALBUTAMOL SULFATE], Nasal spray and antihistamines. Vaccination history included: Bnt162b2 (DOSE 2, lot number: EP6955, ARM LEFT), administration date: 01Apr2021, when the patient was 53 years old, for Covid-19 immunization; Bnt162b2 (DOSE 1, lot number: EL3247, ARM LEFT), administration date: 11Mar2021, when the patient was 53 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (medically significant) with onset 13Dec2021 13:15, outcome "recovering", described as "booster"; ASTHMA (medically significant) with onset 14Dec2021 01:30, outcome "recovering", described as "increased asthma symptoms which brought me into the red zone"; CONDITION AGGRAVATED (medically significant) with onset 14Dec2021 01:30, outcome "recovering", described as "increased asthma symptoms"; CHEST DISCOMFORT (non-serious) with onset 14Dec2021 01:30, outcome "recovering", described as "tightness of chest"; COUGH (non-serious) with onset 14Dec2021 01:30, outcome "recovering", described as "coughing". Therapeutic measures were not taken as a result of immunisation, asthma, condition aggravated, chest discomfort, cough.  No follow-up attempts are needed. No further information is expected.
Administered ID dose to patient under 18 - patient had no adverse effects. We realized the ID dose had been given & let mom know. Mom said patient had no problems.
Sore arm; Body aches; Headache; This is a spontaneous report from a non-contactable consumer. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included mild walnut allergy. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 12:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 20:00, the patient experienced sore arm, body aches and headache. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events sore arm, body aches and headache were resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
I had what I thought were normal vaccine symptoms (soreness at injection site and some muscle stiffness on evening of 7/1/2014).  The next morning more soreness and redness at site.  This progressed thru the day.  On the evening of 7/2 I noticed more redness with a approx 1 inch line running around my arm with considerable pain into armpit.  By morning of 7/3 the red was all the way around my upper arm with increased tenderness and noticeable swelling.  I then made a appointment to be seen in clinic where exam was completed and course of prednisone was started.
Moderna COVID-19 Vaccine EUA  Developed rash on right arm about 7 a.m. on 01/21/2021.  Then about 9:00 a.m. the same day the rash spread to cover my torso, both front and back, and right and left arm but mainly my right arm
pt noticed redness, raised area, warmth @ inj site on 6/2/99 in the afternoon;did put ice on;pt also noted pain;area seen by PA on 6/3/99;pt instructed to apply ice & take Claritin;
Starting 16 hours after injection and lasting until about 36 hours after, I experienced a fever of 100.7° gradually reduce to normal over time, chills, aching joints, and headache.
Hospitalized cough, dyspnea, fatigue, confusion, and gait instability.